Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

189
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
189
Pharmacovigilance01:19

Pharmacovigilance

901
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
901
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

777
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
777
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Non-equilibrium in the Cell01:16

Non-equilibrium in the Cell

4.5K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation.

Endocrine·2026
Same author

Biowaiver based on biopharmaceutics classification system: Considerations and requirements.

Pharmaceutical science advances·2026
Same author

Integrated stability and metabolomic investigation of new rifampicin and isoniazid co-loaded liposome against tuberculosis.

Drug development and industrial pharmacy·2026
Same author

Intranasal administration of thermoresponsive pterostilbene loaded nanoemulgel confers neuroprotection in a rat model of ischemic stroke.

Nanomedicine (London, England)·2025
Same author

Common chemistry, manufacturing, and control deficiencies in abbreviated new drug applications assessed by the US Food and drug administration: Hurdle to access cost-effective medicines.

Journal of pharmacological and toxicological methods·2023
Same author

An overview of regulations for bioequivalence assessment of locally acting orally inhaled drug products for the United States, Europe, Canada, and India.

Expert opinion on drug delivery·2021

相关实验视频

Updated: Jul 23, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K

人工智能在制药监管事务中的作用

Ruchika S Patil1, Samruddhi B Kulkarni1, Vinod L Gaikwad2

  • 1Department of Drug Regulatory Affairs, BVDU Poona College of Pharmacy, Pune 411 038, Maharashtra, India.

Drug discovery today
|July 13, 2023
PubMed
概括

人工智能 (AI) 可以通过自动化文件填写和质量管理等任务来简化复杂的制药监管事务. 这项技术提高了效率,并为现场的人类-人工智能合作创造了新的机会.

更多相关视频

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

318

相关实验视频

Last Updated: Jul 23, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

318

科学领域:

  • 制药科学 制药科学 制药科学
  • 计算机科学 计算机科学
  • 监管事务 监管事务

背景情况:

  • 人工智能 (AI) 涉及计算机执行与人类智能相关的任务,例如学习和解决问题.
  • 制药监管事务管理药物开发和批准的复杂过程.
  • 整合人工智能为简化监管程序提供了一个潜在的解决方案.

研究的目的:

  • 探索人工智能在制药监管事务中的潜在应用和影响.
  • 确定人工智能如何简化和自动化监管流程.

主要方法:

  • 审查与监管任务相关的当前人工智能能力.
  • 在行政工作,文件提交,数据提取,审计,法规实施和质量管理中分析潜在的AI应用.
  • 在监管环境中讨论人与人工智能的交互.

主要成果:

  • 人工智能可以自动化许多监管流程,包括行政任务,档案准备和质量管理.
  • 人工智能集成简化了复杂性,并建立了流程链接,从而导致更有效的监管系统.
  • 人类-人工智能合作在制药监管事务中提供了新的机会.

结论:

  • 人工智能拥有巨大的潜力,通过提高效率和减少复杂性来彻底改变制药监管事务.
  • 由人工智能驱动的自动化和增强的人与人工智能的交互是优化未来监管管理的关键.